Metraipolis › archive › dc_ea508da20422

Alexander Shulgin Research Institute — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-08T07:57:34.566Z
SHA-256 of the archived text
1b3923eabe8393af2699866b7c85cf93f1d1468b13567231828e4f228dc8ed78
Stable URL of this page
https://metraipolis.com/documento/dc_ea508da20422

How to cite

Alexander Shulgin Research Institute — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_ea508da20422 (Metraipolis archive dc_ea508da20422, sha256 1b3923eabe8393af2699866b7c85cf93f1d1468b13567231828e4f228dc8ed78)
BibTeX
@misc{dcea508da20422,
  title = {Alexander Shulgin Research Institute — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_ea508da20422; sha256 1b3923eabe8393af2699866b7c85cf93f1d1468b13567231828e4f228dc8ed78},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Alexander Shulgin Research Institute (ASRI) is an organization developing novel psychedelic and entactogen drugs as potential pharmaceuticals, among other activities. Its goal is to advance the scientific work and legacy of psychedelic chemist Alexander "Sasha" Shulgin and to complete his unfinished projects. The ASRI was informally established by Alexander Shulgin in the 1980s. However, discussions to formally establish the institute began shortly after Shulgin's passing in 2014. The organization was formally incorporated on April 19th, 2021, Bicycle Day, by Ann Shulgin, the late widow of Alexander Shulgin, and by psychedelic chemists and longtime Shulgin research colleagues Paul F. Daley and Nicholas V. Cozzi. Cozzi was the organization's first president between 2020 and 2025. He was succeeded by Daley in March 2025. As of April 2025, ASRI has filed and/or been granted several patents covering various entactogenic and psychedelic compounds. Shulgin himself was not averse to intellectual property (IP) protection and held patents for drugs such as DOM, DOET, Ariadne, and methylone. Pharmaceutical candidates under development at ASRI include ASR-3001 (5-MeO-iPALT; a "second-generation, fast-acting tryptamine" said to produce an internal psychedelic state without sensory or visual disturbances) and ASR-2001 (2CB-5PrO; a phenethylamine-based non-hallucinogenic serotonin 5-HT2A receptor agonist). XOB (ASR-6001), a drug invented by Cozzi, is a dual-action serotonin 5-HT2A receptor antagonist and voltage-gated sodium channel blocker. The company has developed deuterated isotopologues of 2C-B including 2CB-2OCD3 (2-trideuteromethoxy-2C-B) and 2CB-5OCD3 (5-trideuteromethoxy-2C-B), which appear to show similar in-vitro pharmacology as 2C-B. ASRI has more than 500 compounds in its collection, many of which were originally developed by Shulgin. A related initiative is the Alexander Shulgin Archiving Project (or The Shulgin Archive), which is a co-project with Erowid that began by 2007. An earlier group preceding the ASRI was "Team Shulgin", which was formed by 2010 and comprised Alexander and Ann Shulgin, Ann Shulgin's daughter Wendy Tucker (the editor of PiHKAL and TiHKAL and the head of Transform Press), Paul Daley, Tania Manning, and Greg Manning.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Alexander Shulgin Research Institute» — https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute
Wikidata Q133278620 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q133278620
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Alexander_Shulgin_Research_Institute?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1368571126, consultata il 2026-11-08T07:51:45.972Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: b02181fedf7f30ef7dc3770c29485c7d6b484e5a58e40f8c4884e1ab75487400